Home › Ovarian Cancer › Ohio › Dayton

Ovarian Cancer clinical trials in Dayton, OH

9 studies for Ovarian Cancer are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2

Miami Valley Hospital, Dayton
Premier Blood and Cancer Center, Dayton
Miami Valley Hospital North, Dayton
and 5 more

All ages · All sexes · Updated Oct 5, 2026 · NCT05564377

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RecruitingPhase 2

Kettering Medical Center /ID# 274365, Kettering · 5 mi away

Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecruitingPhase 3

Miami Valley Hospital South, Centerville · 9 mi away

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

RecruitingPhase 3

Miami Valley Hospital South, Dayton

Ages 18 and older · Women · Updated Sep 15, 2026 · NCT07214779

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

RecruitingPhase 3

Miami Valley Hospital South, Centerville · 9 mi away

Ages 18 and older · Women · Updated Sep 9, 2026 · NCT07225270

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

RecruitingPhase 3

Kettering Health, Kettering · 5 mi away

Ages 18 and older · Women · Updated Aug 26, 2026 · NCT05281471

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting

Miami Valley Hospital, Dayton
Miami Valley Hospital North, Dayton
Miami Valley Hospital South, Centerville · 9 mi away
and 2 more

Ages 35 to 50 · Women · Updated Aug 7, 2026 · NCT04251052

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

RecruitingPhase 2

304, Centerville · 9 mi away

Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

RecruitingPhase 3

Miami Valley Hospital South, Centerville · 9 mi away

Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Dayton

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.